Sands Stephen's Insider Trades & SAST Disclosures
Sands Stephen's most recent trade in Bicycle Therapeutics Plc - ADR was a trade of 10,787 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sands Stephen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicycle Therapeutics Plc -... | Stephen Sands | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,787 | 10,787 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Stephen Sands | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,393 | 17,393 | - | 0 | Ordinary Shares | |
| Bicycle Therapeutics Plc -... | Sands Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Sands Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 12,000 | 12,000 | - | 0 | Ordinary Shares | |
| Cyteir Therapeutics Inc | Sands Stephen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. | 09 Feb 2024 | 12,129 | 12,129 | - | 1.7 | 20,498 | Common Stock |
| Cyteir Therapeutics Inc | Sands Stephen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 12,129 | 0 | - | - | Stock Option (Right to Buy) | |
| Cyteir Therapeutics Inc | Stephen Sands | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 12,129 | 12,129 | - | - | Stock Option (Right to Buy) | |
| Cyteir Therapeutics Inc | Stephen Sands | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 28,300 | 28,300 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges